Uri Geiger - 30 Jun 2023 Form 4 Insider Report for NeuroPace Inc (NPCE)

Role: Director
Signature: /s/ Leah Akin, Attorney-in-Fact
Issuer symbol: NPCE
Transactions as of: 30 Jun 2023
Net transactions value: +$105,432
Form type: 4
Filing time: 24 Jun 2025, 16:30:17 UTC
Previous filing: 14 Jun 2023
Next filing: 11 Jun 2024
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Geiger Uri	Director	C/O NEUROPACE, INC., 455 N. BERNARDO AVENUE, MOUNTAIN VIEW	/s/ Leah Akin, Attorney-in-Fact	24 Jun 2025	0001467361

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NPCE	Common Stock	Award	$10,493	+2,337		$4.49	2,337	30 Jun 2023	Direct	F1
transaction	NPCE	Common Stock	Award	$11,871	+1,220	+52%	$9.73	3,557	29 Sep 2023	Direct	F1
transaction	NPCE	Common Stock	Award	$11,867	+1,151	+32%	$10.31	4,708	29 Dec 2023	Direct	F1
transaction	NPCE	Common Stock	Award	$11,867	+899	+19%	$13.20	5,607	29 Mar 2024	Direct	F1
transaction	NPCE	Common Stock	Award	$11,869	+1,570	+28%	$7.56	7,177	28 Jun 2024	Direct	F1
transaction	NPCE	Common Stock	Award	$11,870	+1,703	+24%	$6.97	8,880	30 Sep 2024	Direct	F1
transaction	NPCE	Common Stock	Award	$11,864	+1,029	+12%	$11.53	9,909	21 Dec 2024	Direct	F1
transaction	NPCE	Common Stock	Award	$11,864	+987	+10%	$12.02	10,896	21 Mar 2025	Direct	F1
transaction	NPCE	Common Stock	Award	$11,867	+1,140	+10%	$10.41	12,036	21 Jun 2025	Direct	F1
holding	NPCE	Common Stock						4,432,948	30 Jun 2023	See footnote	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees.
F2	Shares are held by Accelmed Partners II LP. Accelmed Partners II, LLC ("Accelmed LLC") is the general partner of Accelmed Partners II GP, L.P., which is the general partner of Accelmed Partners II LP. Uri Geiger is the managing partner of Accelmed LLC and has sole voting and dispositive power with respect to the shares held by Accelmed Partners II LP. Dr. Geiger, a member of our board of directors, is a General Partner at Accelmed LLC.

Content

These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees.

Shares are held by Accelmed Partners II LP. Accelmed Partners II, LLC ("Accelmed LLC") is the general partner of Accelmed Partners II GP, L.P., which is the general partner of Accelmed Partners II LP. Uri Geiger is the managing partner of Accelmed LLC and has sole voting and dispositive power with respect to the shares held by Accelmed Partners II LP. Dr. Geiger, a member of our board of directors, is a General Partner at Accelmed LLC.